Alembic Pharmaceuticals Limited (APLLTD.NS) NSE

856.00

-1.4(-0.16%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap176.29B
Enterprise Value187.96B
P/E Ratio26.52
PEG Ratio5.05
Price/Sales Ratio2.38
Price/Book Ratio3.16
Enterprise/Revenue2.57
Enterprise/EBITDA16.28

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.31

Management Effectiveness

Return On Assets0.08
Return On Equity0.12

Income Statement

Revenue66.72B
Revenue/Share360.35
Gross Profit47.91B
EBITDA9.89B
Net Income5.83B
Diluted EPS29.68

Balance Sheet

Total Cash1.55B
Total Cash/Share7.89
Total Debt14.89B
Total Debt/Equity0.28
Current Ratio1.59
Book Value Per Share270.45

Price History

52-Week Change-17.33
52-Week High1,123.95
52-Week Low725.2
Moving Average 50 Days904.61
Moving Average 200 Days933.89

Statistics

Average Volume174,750
Shares Outstanding196.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate11
Trailing Annual Dividend Yield1.29
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A